Wegovy (semaglutide) In STEP 1, 85% of participants using semaglutide reported at least one gastrointestinal side effect, but these were mostly mild to moderate in severity
A meta-analysis of weight loss clinical trials mediated by lifestyle interventions showed an average weight loss of 5% to 9% in the first 6 months, which back-tracked to 3% to 6% in those studies where 48-month data were available (9)
The 30-60-90 Framework A simple way to stay on track, especially during those final days of the week when the medication levels are lower, is to follow a consistent lifestyle routine: 30 Minutes of Movement: Daily physical activity helps maintain muscle mass and supports your metabolism
These interactions between antioxidants, enzymatic antioxidants, and other physiological enzymes are crucial for developing strategies to promote a healthy life and prevent or manage diseases arising from oxidative stress
Incremental Dosage Adjustments Based on Patient Response Adjusting the dosage of semaglutide is essential to balance efficacy and tolerability